share_log

Pfizer | 8-K: Pfizer Reports First-Quarter 2024 Results

Pfizer | 8-K: Pfizer Reports First-Quarter 2024 Results

辉瑞 | 8-K：辉瑞公布2024年第一季度业绩
美股sec公告 ·  05/01 08:14
Moomoo AI 已提取核心信息
On May 1, 2024, Pfizer Inc., a pharmaceutical giant, announced its financial results for the first quarter of 2024. The announcement was made through a press release which is now furnished as Exhibit 99 and incorporated by reference. Pfizer, listed on the New York Stock Exchange under the ticker PFE, has made this information available in accordance with the requirements of the Securities Exchange Act of 1934. The details of the financial results were not disclosed in the announcement. However, the press release is expected to provide a comprehensive overview of the company's financial performance during the quarter. Pfizer's common stock and 1.000% Notes due 2027 are both traded on the New York Stock Exchange. The company has confirmed that the information provided in the press release, including the financial results, is not to be considered 'filed' for regulatory purposes and is not incorporated by reference into any of their other filings, unless explicitly stated.
On May 1, 2024, Pfizer Inc., a pharmaceutical giant, announced its financial results for the first quarter of 2024. The announcement was made through a press release which is now furnished as Exhibit 99 and incorporated by reference. Pfizer, listed on the New York Stock Exchange under the ticker PFE, has made this information available in accordance with the requirements of the Securities Exchange Act of 1934. The details of the financial results were not disclosed in the announcement. However, the press release is expected to provide a comprehensive overview of the company's financial performance during the quarter. Pfizer's common stock and 1.000% Notes due 2027 are both traded on the New York Stock Exchange. The company has confirmed that the information provided in the press release, including the financial results, is not to be considered 'filed' for regulatory purposes and is not incorporated by reference into any of their other filings, unless explicitly stated.
2024年5月1日，制药巨头辉瑞公司公布了2024年第一季度的财务业绩。该公告是通过新闻稿发布的，该新闻稿现作为附录99提供，并以引用方式纳入。辉瑞在纽约证券交易所上市，股票代码为PFE，根据1934年《证券交易法》的要求提供了这些信息。公告中没有披露财务业绩的细节。但是，预计该新闻稿将全面概述该公司本季度的财务业绩。辉瑞的普通股和2027年到期的1.000％票据均在纽约证券交易所上市。该公司已确认，除非明确说明，否则新闻稿中提供的信息，包括财务业绩，不应被视为 “已提交”，也不会以引用方式纳入其任何其他申报中。
2024年5月1日，制药巨头辉瑞公司公布了2024年第一季度的财务业绩。该公告是通过新闻稿发布的，该新闻稿现作为附录99提供，并以引用方式纳入。辉瑞在纽约证券交易所上市，股票代码为PFE，根据1934年《证券交易法》的要求提供了这些信息。公告中没有披露财务业绩的细节。但是，预计该新闻稿将全面概述该公司本季度的财务业绩。辉瑞的普通股和2027年到期的1.000％票据均在纽约证券交易所上市。该公司已确认，除非明确说明，否则新闻稿中提供的信息，包括财务业绩，不应被视为 “已提交”，也不会以引用方式纳入其任何其他申报中。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息